TuesdayJun 04, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Announces Updates on ACT-EAP for CNM-Au8(R) Compassionate Use

Clene announced significant updates to their NIH-funded Accelerating Access to Critical Therapies Expanded Access Program (ACT-EAP) for CNM-Au8(R) compassionate use in amyotrophic lateral sclerosis (“ALS”) Clene has optimized its manufacturing, operational, and personnel processes to expand the program’s capacity to accommodate up to 180 participants The ACT-EAP, a collaboration among Clene, Columbia University, and Synapticure, was funded by the Accelerating Access to Critical Therapies for ALS Act (ACT for ALS), signed into law by Congress and President Biden in December 2021 Clene (NASDAQ: CLNN) and its subsidiary, Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company dedicated to improving mitochondrial health and protecting…

Continue Reading

MondayJun 03, 2024 10:00 am

Virginia Tech Clinical Trial Seeks End to Brain Cancer Surgery

Patients with brain cancer often undergo surgery to treat the disease because this is the recommended treatment for this particular cancer. This doesn’t mean that surgery is always an option, as treatments for patients are often prescribed by their primary care providers. A trial conducted at the Virginia-Maryland College of Veterinary Medicine (Virginia Tech) looked into whether noninvasive treatments would do away with surgery in the management of brain cancer. For their study, the researchers used dogs to test out the effectiveness of focused ultrasound therapy, in particular histotripsy, in getting rid of brain tumors. Lauren Ruger, a postdoctoral research…

Continue Reading

MondayJun 03, 2024 8:45 am

HealthLynked Corp. (HLYK) Continues to Expand AI Capabilities

HealthLynked is at the forefront of revolutionizing global healthcare related solutions for patients, doctors, and related healthcare organizations Some of the company’s solutions, including the HealthLynked Network, Augmented Real-Time Interface, and the new AI chat feature, incorporate artificial intelligence capabilities to foster better patient outcomes for all The new AI chat feature is designed to assist patients in locating healthcare providers across the country using markers such as name, specialty, or location and significantly enhance the effectiveness of the HealthLynked Concierge Team in reducing wait times and offering 24/7 service to users HealthLynked continues to lead in the development of…

Continue Reading

FridayMay 31, 2024 10:00 am

Breakthrough Research Uncovers Benefits of Hidden Respiratory Disease Diagnosis

A recently conducted clinical trial has determined that treating individuals with undiagnosed chronic obstructive pulmonary disease or asthma improved their health and decreased healthcare visits for respiratory symptoms in the time they were diagnosed. To find individuals with the undiagnosed illnesses, the scientists dialed random numbers at different sites across Canada between 2017 and 2023. During the calls, respondents were asked whether there were any persons in the house who experienced unexplained prolonged coughs, wheezing or shortness of breath, or who were coughing up mucus. As a result of the calls, more than 26,000 individuals with these symptoms completed questionnaires.…

Continue Reading

WednesdayMay 29, 2024 10:30 am

PaxMedica Inc. (NASDAQ: PXMD) Shares Corporate Update and Commitment to Advancing Therapies for Neurological Disorders, Prepares for Key Engagements with the FDA

PaxMedica is preparing to submit a New Drug Application to the U.S. Food and Drug Administration later this year for using suramin to treat Human African Trypanosomiasis PaxMedica is currently preparing for an associated and very important Type C meeting with the FDA scheduled for June 27th Type C meetings are designated by the FDA to address specific issues in drug development, such as clinical trial design, data requirements, or other scientific matters not covered by Type A or Type B meetings PaxMedica (NASDAQ: PXMD), a biopharmaceutical company specializing in neurological disorder treatments, recently shared corporate updates regarding its continued…

Continue Reading

WednesdayMay 29, 2024 10:00 am

Understanding Medigap vs. Medicare Advantage Plans

Medicare is a health insurance program that caters to aging persons at a fee. While the program provides a range of benefits and different types of coverage, it has its issues. To help with this, individuals should consider enrolling in a Medigap or Advantage plan. What is Medicare Advantage? Medicare Advantage, which is sometimes referred to as Part C, is offered by private insurers and is basically an individual’s primary insurance. It provides all benefits under Medicare as well as additional ones, including vision, dental, hearing and fitness coverage. Individuals eligible for the Advantage plan include younger individuals with disabilities,…

Continue Reading

FridayMay 24, 2024 10:00 am

Study Discovers Elevated Risk of Toxicity Among Autistic Kids

In the last couple of decades, the number of individuals being diagnosed with attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD) has greatly increased. Researchers hypothesize that disorders such as ADHD and ASD are caused by a combination of environmental and genetic factors. One study found that there’s a difference in how kids with ADHD or autism eliminate bisphenol A from their bodies, in comparison to neurotypical kids. Bisphenol A (BPA) is a common plastic additive used in plastic production processes. It can also be found inside drink and food cans. Prior studies have also linked the plastic…

Continue Reading

FridayMay 24, 2024 9:45 am

Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy

Clene recently participated in the Mizuho Neuroscience Summit 2024, the Benchmark 2024 Healthcare House Call Virtual Conference, and the Virtual A.G.P. Healthcare Conference CNM-Au8(R) is oral suspension developed to restore neuronal health and function by increasing energy production and utilization The therapy has been involved in clinical trials and compassionate use programs, accumulating over 600 years of exposure across various neurodegenerative conditions, with no safety concerns reported Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”), multiple sclerosis (“MS”), and Parkinson’s disease, recently…

Continue Reading

FridayMay 24, 2024 9:00 am

PaxMedica Inc. (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher Program in Wake of Malawi Major Sleeping Sickness Crisis

PaxMedica has received an urgent plea from the Ministry of Health of Malawi for emergency access to IV suramin to prevent a potential humanitarian crisis due to dwindling supplies of essential drugs used to save lives in the region PaxMedica has previously concluded a Type B meeting with the FDA in preparation for the NDA submission, focusing on the use of PAX-101 in treating the rare and fatal trypanosomal infection, Trypanosoma brucei rhodesiense, transmitted by tsetse flies PaxMedica also aims to potentially qualify for a Priority Review Voucher under the Neglected Tropical Disease Priority Review Voucher Program, which could provide…

Continue Reading

ThursdayMay 23, 2024 9:00 am

HealthLynked Corp. (HLYK) Can Add Tens-of-thousands of Members by Improving Care for Students vis-à-vis its Affinity Marketing Efforts to U.S. Universities

The HealthLynked platform provides secure and quick access for patient/doctor records communication, supporting all types of health related utilization, including telemedicine and remote student applications University health clinics often face challenges when transferring medical records – and this limits coordinated care for students The HealthLynked platform provides a streamlined approach to medical records access, allowing students to securely share their health information with relevant parties HealthLynked (OTCQB: HLYK) is a company on a mission to build a superior healthcare system through the efficient integration of patient histories, genetic data, and demographic insights, into a sophisticated AI-driven platform that streamlines patient care…

Continue Reading

Official NewsWire Relationships

BIO Informa DGE Dynamic Global Events DTC Healthcare Conference Kiasco Reasearch Nexus Conferences Octane

BioMedWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050